Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The outcome ofancy. COVID-19 in patients with hematological malign.
Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Turgut B, Altuntas F. Yigenoglu TN, et al. J Med Virol. 2021 Mar;93(3):1255. doi: 10.1002/jmv.26607. Epub 2020 Nov 1. J Med Virol. 2021. PMID: 33064307 Free PMC article. No abstract available.
Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
Dal MS, Tekgündüz E, Çakar MK, Kaya AH, Namdaroğu S, Batgi H, Bekdemir F, Uncu Ulu B, Yiğenoğlu TN, Kılınç A, İskender D, Uğur B, Koçubaba Ş, İskender G, Altuntaş F. Dal MS, et al. Among authors: yigenoglu tn. Transfus Apher Sci. 2016 Aug;55(1):125-8. doi: 10.1016/j.transci.2016.05.001. Epub 2016 May 6. Transfus Apher Sci. 2016. PMID: 27184293
The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma.
Çakar MK, Tekgündüz E, Dal MS, Merdin A, Başçı S, İskender D, Uğur B, Bekdemir F, Yıldız J, Ulu BU, Bakırtaş M, Yiğenoğlu TN, Batgi H, Kaya AH, İskender D, Altuntaş F. Çakar MK, et al. Among authors: yigenoglu tn. J Oncol Pharm Pract. 2020 Mar;26(2):273-278. doi: 10.1177/1078155219841110. Epub 2019 Apr 2. J Oncol Pharm Pract. 2020. PMID: 30940050
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.
Merdin A, Çakar MK, Dal MS, Mert D, Yıldız J, Başçı S, Bakırtaş M, Darçın T, Şahin D, Ulu BU, Yiğenoğlu TN, Batgi H, Tetik A, İskender D, Altuntaş F. Merdin A, et al. Among authors: yigenoglu tn. J Oncol Pharm Pract. 2020 Jun;26(4):929-932. doi: 10.1177/1078155219891663. Epub 2019 Dec 10. J Oncol Pharm Pract. 2020. PMID: 31822199
The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors.
Yiğenoğlu TN, Başcı S, Bakırtaş M, Ulu BU, Kılınç A, Şahin D, Darçın T, Yıldız J, Merdin A, Baysal NA, İskender D, Çakar MK, Dal MS, Hacıbekiroğlu T, Altuntaş F. Yiğenoğlu TN, et al. Transfus Apher Sci. 2020 Jun;59(3):102726. doi: 10.1016/j.transci.2020.102726. Epub 2020 Jan 9. Transfus Apher Sci. 2020. PMID: 32008954
Inferior prognosis in poor mobilizing myeloma patients.
Yiğenoğlu TN, Başcı S, Ulu BU, Bakırtaş M, Kılınç A, Şahin D, Darçın T, Yıldız J, Baysal NA, İskender D, Çakar MK, Dal MS, Hacıbekiroğlu T, Altuntaş F. Yiğenoğlu TN, et al. Transfus Apher Sci. 2020 Jun;59(3):102722. doi: 10.1016/j.transci.2020.102722. Epub 2020 Jan 9. Transfus Apher Sci. 2020. PMID: 32014363
Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study.
Büyükaşık Y, Ali R, Turgut M, Saydam G, Yavuz AS, Ünal A, Ar MC, Ayyıldız O, Altuntaş F, Okay M, Çiftçiler R, Meletli Ö, Soyer N, Mastanzade M, Güven Z, Soysal T, Karakuş A, Yiğenoğlu TN, Uçar B, Gökçen E, Tuğlular T. Büyükaşık Y, et al. Among authors: yigenoglu tn. Turk J Haematol. 2020 Aug 28;37(3):177-185. doi: 10.4274/tjh.galenos.2020.2019.0431. Epub 2020 Feb 20. Turk J Haematol. 2020. PMID: 32075363 Free PMC article.
The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience.
Batgi H, Merdin A, Dal MS, Kızıl Çakar M, Yıldız J, Başçı S, Uncu Ulu B, Yiğenoğlu TN, Darçın T, Şahin D, Bakırtaş M, Tetik A, İskender D, Altuntaş F. Batgi H, et al. Among authors: yigenoglu tn. J Oncol Pharm Pract. 2020 Dec;26(8):1857-1863. doi: 10.1177/1078155220905654. Epub 2020 Feb 25. J Oncol Pharm Pract. 2020. PMID: 32098553
46 results